Perspective Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CATX | MNPR | ATNM | MGNX | CRDF | ALXO | |
|---|---|---|---|---|---|---|
| Market cap | 99.33M | 488.71M | 44.33M | 147.15M | 67.60M | 188.06M |
| P/E (TTM) | — | — | 3.9 | — | — | — |
| Forward P/E | -0.8 | -38.0 | -2.7 | -1.6 | -1.6 | -2.5 |
| Price/book | 0.3 | 3.7 | 1.5 | 3.4 | 2.2 | 1.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −62.23% | −15.28% | +4.48% | +61.81% | −61.61% | +2.38% |
| Today | −1.11% | +4.18% | +0.71% | −0.86% | +0.67% | +5.43% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All CATX news ›Wedbush Sticks to Their Buy Rating for Fate Therapeutics (FATE)
In a report released today, from Wedbush maintained a Buy rating on Fate Therapeutics, with a price target of $7.00. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Fate Therapeutics with a $6.63…
Analysts Conflicted on These Healthcare Names: Perspective Therapeutics (CATX), Bristol-Myers Squibb (BMY) and Incyte (INCY)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Perspective Therapeutics (CATX), Bristol-Myers Squibb (BMY) and Incyte (INCY). In a report released yesterday, Leonid Timashev from RBC…
Perspective Therapeutics (CATX) Receives a Buy from Wedbush
Wedbush analyst maintained a Buy rating on Perspective Therapeutics today and set a price target of $11.00. In a report released today, Truist Financial also maintained a Buy rating on the stock with a $11.00 price target. Based on…
Protalix: HOLD Alapkezelo Zrt. reports 5.2% stake
A Hungarian fund manager reports a stake above 5% in Protalix BioTherapeutics (PLX). Stock Titan - [SCHEDULE 13G] Protalix BioTherapeutics, Inc. Passive Investment Disclosure (>5%) Protalix: HOLD Alapkezelo Zrt. reports 5.2% stake HOLD…
Journey Medical: Wasatch reports 11% passive stake
An investment adviser reports passive ownership of 2.45M shares in Journey Medical (DERM). Stock Titan - [SCHEDULE 13G/A] Journey Medical Corp Amended Passive Investment Disclosure Journey Medical: Wasatch reports 11% passive stake Wasatch…
Collegium Pharma: Millennium reports 7.4% stake
Four investors report shared voting power over Collegium Pharma (COLL) shares. Stock Titan - [SCHEDULE 13G/A] COLLEGIUM PHARMACEUTICAL, INC Amended Passive Investment Disclosure Collegium Pharma: Millennium reports 7.4% stake The same…
Perspective Therapeutics’ (CATX) “Buy” Rating Reiterated at BTIG Research
Perspective Therapeutics (NYSEAMERICAN:CATX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at BTIG Research in a report issued on Wednesday, Benzinga reports. They presently have a $14.00 price target on the…
Perspective Therapeutics (CATX) Gets a Hold from Bank of America Securities
Bank of America Securities analyst Alec Stranahan maintained a Hold rating on Perspective Therapeutics today and set a price target of $5.00. Stranahan covers the Healthcare sector, focusing on stocks such as Moderna, Revolution Medicines,…
Analysts Are Bullish on These Healthcare Stocks: Nurix Therapeutics (NRIX), Perspective Therapeutics (CATX)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Nurix Therapeutics (NRIX) and Perspective Therapeutics (CATX) with bullish sentiments. Oppenheimer analyst Kostas Biliouris reiterated a Buy…
Perspective Therapeutics Inc trading resumes
11:05 EDT Perspective Therapeutics (CATX) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving brea... Perspective Therapeutics Inc trading resumes 11:05 EDT Perspective Therapeutics (CATX) Inc…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.businessinsider.com15
- stocktitan.net4
- defenseworld.net3
- quiverquant.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 23 articles, not a forecast.